Prairie Hills Health
- Laser Therapy (LLLT)
- Hyperbaric Oxygen Therapy (HBOT)
- Chelation Therapy
- Lyme Disease Treatment
- Red Light Therapy
Tulsa, OK
Chelation therapy in Tulsa is offered by a small set of integrative and naturopathic clinics, typically for documented heavy metal toxicity confirmed by provocation or baseline testing. Common agents include calcium disodium EDTA, DMPS, DMSA, and deferoxamine, each with specific binding profiles for lead, mercury, arsenic, or iron.
Most Tulsa chelation providers are MDs or DOs with ACAM training, and in some states naturopathic doctors within their licensed scope. Protocols vary from 10-session courses for basic detoxification to longer 30-session cardiovascular protocols modeled on the TACT trial. Pricing is cash-pay in almost every case, and no insurance covers off-label chelation.
With verified chelation therapy clinics on Regenerated.com in Tulsa, Oklahoma, patients can compare provider credentials, testing protocols, and agent selection. Regenerated.com does not recommend chelation for cardiovascular disease or autism. The FDA has only approved specific agents for specific heavy metal poisoning diagnoses. Chelation outside that narrow indication is off-label, and in the wrong hands it has caused deaths.
Regulatory context
The FDA has approved a narrow set of chelating agents for specific heavy metal toxicities. Calcium disodium edetate (CaNa2EDTA, Versenate) is approved for symptomatic lead poisoning, succimer (Chemet, DMSA) for pediatric lead poisoning at blood lead levels above 45 mcg/dL, deferoxamine (Desferal) and deferasirox (Exjade) for chronic iron overload, and dimercaprol (BAL) for arsenic, gold, and acute lead poisoning. Use of EDTA chelation for cardiovascular disease was studied in the NIH-funded TACT trial (2013) with controversial findings and remains not FDA-approved for that indication. Chelation for autism spectrum disorder is not evidence-based and has been linked to pediatric deaths. The FDA issued a 2010 sweep of warning letters to compounders marketing OTC chelation products with unapproved disease claims.
The Oklahoma State Board of Medical Licensure and the Oklahoma State Board of Osteopathic Examiners have investigated chelation practitioners for marketing claims tied to non-approved indications. Oklahoma does not license NDs. Tulsa and Oklahoma City have notable integrative medicine communities. The Oklahoma osteopathic board has historically been more permissive on integrative therapies including chelation. The 2005 Pittsburgh pediatric chelation death informs board expectations.